… MOR1 has been found in several types of cancer cells and reported to be … cell carcinoma
(ESCC) remain unclear. In our study, the expression of MOR1 was confirmed in ESCC cell lines …

… experimental data suggest that opioids might promote tumour … opioid receptors and their
role in directly regulating cellular … mu-opioid receptor (MOP) is the main target for most opioids …

… Expression of the mu-opioid receptor (MOR) is associated with … in laryngeal squamous cell
carcinoma (LSCC) is not clear. … oesophageal squamous cell carcinoma or colorectal cancers. …

… opioids was associated with worse survival in patients undergoing surgery for laryngeal
squamous cell carcinoma (5). The mu-opioid receptor (MOR) is the site of action of prescription …

… Opioids are still the most effective and widely used treatments for acute and chronic pain in
cancer patients. This review focuses on the impact of opioids and mu-opioid … cell carcinoma …

… human squamous cell carcinoma of the head and neck, low-dose naltrexone (0.1 mg/kg)
significantly reduced tumor volume by up to 84%. This was accomplished without exogenous …

… target for most clinically used opioids, including morphine. A … opioid use and pancreatic
cancer (PC) progression. We found increased MOR expression in murine and human PC cell …

… A panel of 70 squamous cell carcinoma cell line was used in this study. Their short tandem
repeat and genomic profiles were previously published, as well as their transcriptome profile (…

… carcinoma, adenocarcinoma, or squamous cell carcinoma lung cancer and adjacent
normal tissue. The microscopic images of each slide were scanned and analyzed using …

… tumor cell proliferation and angiogenesis; no changes in cell survival were … opioid receptor
blockade with a low dose of NTX on the progression of established squamous cell carcinoma …